Skip to main content

Table 3 OHSS outcomes of high-risk treatment and control groups

From: Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

  Treatment groups (n = 161) Control group
Letrozole group Mifepristone group GnRH-ant group Three-drug group
(n = 43) (n = 51) (n = 39) (n = 28) (n = 120)
Paracentesis (n) 7 (16.3 %) 9 (17.7 %) 7 (17.9 %) 4 (14.3 %) 21 (19.2 %)
Length of hospital stay(days) 7.0 ± 2.9 7.4 ± 2.5 7.1 ± 2.8 6.8 ± 2.1 7.3 ± 2.7
Severity of OHSS      
 Mild (n) 24 (55.8 %) 26 (51.0 %) 19 (48.7 %) 15 (53.6 %) 65 (54.2 %)
 Moderate (n) 12 (27.9 %) 15 (29.4 %) 13 (33.3 %) 8 (25.0 %) 33 (27.5 %)
 Severe (n) 7 (16.3 %) 10 (19.6 %) 7 (18.0 %) 5 (17.9 %) 22 (18.3 %)
Complications (n) 0 0 0 0 1b
Luteal phase(days)a 10.9 ± 2.6 10.5 ± 1.9 10.7 ± 2.4 10.4 ± 2.3 11.2 ± 3.1
  1. Values are means ± SD unless otherwise stated. Values in parentheses are percentages. OHSS ovarian hyperstimulation syndrome, NS not statistically significant
  2. aLuteal phase = interval between oocyte retrieval and next menstrual cycle
  3. bOne patient experienced ovarian torsion